Hong Kong Electrical Stock News

HKBN reported that on 11 September 2026, Ling Hao stepped down as executive director, chairman and nomination committee chair, with China Mobile Hong Kong chief executive Shi Xiaoping taking over all three roles. The move brings HKBN a leader with over 25 years of telecom execution experience across network build out, operations, compliance and enterprise-facing services. This could influence how the business prioritises broadband, ICT and partnership decisions. It remains to be seen how...

Shenzhen International Holdings (SEHK:152) has completed a fresh RMB 1,000 million medium term note issuance at a 2.07% coupon and 10 year maturity, giving investors new information on its long term funding mix. Set against that new funding, Shenzhen International Holdings’ share price has been choppy. The stock is up 5.06% on a 1 month share price return but down 38.50% on a year to date share price return, while the 3 year total shareholder return of 30.17% contrasts with a 1 year total...

CSPC Pharmaceutical Group recently reported a cluster of R&D milestones, including multiple NMPA clinical trial approvals and a new Breakthrough Therapy Designation across neurological, oncology, ophthalmology and infectious disease programs. This run of new Parkinson’s, solid tumour, dry eye, influenza and head and neck cancer candidates points to more intensive R&D execution, a broader late stage workload and potentially higher development costs alongside a more diversified future revenue...

Henderson Land Development (SEHK:12) has drawn attention after recent share performance data showed the stock flat on the day but down over the past week, month and past 3 months. Investors are reassessing what that means for value and income potential. Viewed over a longer stretch, Henderson Land Development has a 1-year total shareholder return that is down 4.24%, even as the 3-year total shareholder return sits at 55.64%. This suggests that longer term holders have seen gains while shorter...

Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) just cleared an important hurdle. Positive phase III data for its HER2 antibody drug trastuzumab botidotin, together with Chinese regulatory approval, now anchors a key part of the investment story. In the short term, the Sichuan Kelun-Biotech Biopharmaceutical share price has pulled back. The 1-day move is down 3.91% and the 30-day share price return is down 11.16%. However, the 90-day share price return is up 14.63% and the 3-year total...

Simcere Pharmaceutical Group (SEHK:2096) has hit two major milestones within days. Chinese regulators approved its Culevibart Injection for RSV prevention in newborns and infants, and Roche licensed SIM0660 with material upfront, milestone and royalty economics. These twin announcements have come as Simcere Pharmaceutical Group’s share price has climbed 14.59% over the past 90 days, even though the 1-year total shareholder return is down 15.46% and the 3-year total shareholder return is up...

Keymed Biosciences (SEHK:2162) has moved back into focus after signing an exclusive licensing and commercialization agreement with Aeira that covers its IL-4Ra-targeted antibody Kangyueda across Southeast and Central Asia. Recent trading has been choppy for Keymed Biosciences. The share price is up 2.60% over the past day to HK$74.95, yet the 7 day and 30 day share price returns are down 4.03% and 4.09%. The 90 day and year to date share price returns of 33.13% and 40.22% point to stronger...

TCL Electronics used IFA 2026 to showcase its AI Inspired Life concept, unveiling X11L SQD Mini LED TVs, RayNeo GT Max Dolby Vision AR glasses, the NXTHOME smart home ecosystem, AI-powered appliances and new S-Class Dolby Atmos soundbars that link entertainment, appliances and energy solutions into one connected experience. The breadth of TCL Electronics' product slate, from premium Mini LED displays and AR wearables through to AI-driven air conditioning, laundry and audio, points to a push...

Lenovo Group (SEHK:992) has just put a spotlight on its AI and hardware roadmap at Lenovo Innovation World '26, unveiling the AeroBlade concept notebook, wider Lenovo and Motorola Qira services, fresh Yoga and Idea devices, and a new workflow partnership with Workato. For context, Lenovo Group’s share price has climbed strongly over the year, with a year to date share price return of 236.54% and a very large 5 year total shareholder return of 382.60%. However, the 30 day share price return of...

Hong Kong and China Gas (SEHK:3) recently drew investor attention after fresh performance figures showed modest revenue and net income growth, along with total returns that differ sharply between the past 3 years and the longer 5 year period. Recent trading has been mixed for Hong Kong and China Gas, with the 30-day share price return of 5.19% and 90-day gain of 5.74% contrasting with a year-to-date share price move that is roughly flat. The 3-year total shareholder return of 50.33% points to...

Lingbao Gold Group (SEHK:3330) has been drawing fresh attention after recent share price moves, with the stock up over the past month and past 3 months, prompting investors to reassess its valuation. Short term momentum for Lingbao Gold Group has cooled slightly, with the share price slipping 0.94% over the past day, although a 30 day share price return of 8.68% and a 90 day gain of 50.19% point to strong recent interest. Over a longer horizon, total shareholder return has been very large,...

As global markets navigate the complexities of geopolitical tensions and fluctuating oil prices, Asian equities have shown resilience, with growth companies continuing to capture investor interest. In this environment, stocks with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the business.

As inflation concerns and geopolitical tensions continue to shape global markets, Asian indices have experienced fluctuations, reflecting broader economic uncertainties. Despite these challenges, investors often find potential in smaller or newer companies that are categorized as penny stocks—a term that may seem outdated but still signifies a niche investment area. By focusing on those with robust financials and clear growth trajectories, investors can discover opportunities among these...

BYD (SEHK:1211) has put fresh production and sales figures on the table for August 2026, giving investors new monthly datapoints to weigh against a softer year to date delivery picture. Recent share price action suggests investors are still cautious. The stock has fallen 9.1% on a 30 day share price return basis and is down 18.8% year to date, while the 1 year total shareholder return has declined 25.5%. This points to fading momentum despite BYD’s latest operational update. Scan the EV space...

China Overseas Property Holdings was removed from the Hang Seng China Affiliated Corporations Index on 7 September 2026, which can affect how index-tracking funds and benchmarked portfolios hold the stock. The index exit raises questions for investors about the company’s liquidity profile, perceived scale within the China-affiliated universe, and how management prioritises growth relative to capital efficiency. We will assess how China Overseas Property Holdings' exit from the Hang Seng...

HKT Trust and HKT has delivered a strong share price run in recent years, which naturally puts the focus on whether the current level is fully backed by the cash it can generate. For investors watching HKT Trust and HKT today, the key issue is how that market performance lines up with an intrinsic value estimate based on its cash flows. Over the past 3 years the stock has gained 84.6%, which raises the question of how much of that move is supported by the cash the business is expected to...

Recent Share Performance and Business Context Recent trading in Shanghai Fudan Microelectronics Group (SEHK:1385) has drawn attention as the stock has declined 3.1% over the past day and is down 9.1% over the past week. The pullback extends through the past month and past 3 months, with the share price falling 9.8% and 14.8% respectively, while the year to date performance shows a decline of 49.1%. Over a longer horizon the total return over the past year is down 36.2%, although the 3-year...

CLP Holdings has delivered a solid share price run in recent years, which naturally puts fresh attention on what investors are paying for its future cash flows. With the stock now at HK$78.25, the key issue is how that price stacks up against what the company is expected to generate in cash over time. Over the past 3 years, CLP Holdings has returned 53.5%. This puts a lot of past optimism on the line when you test the share price against the underlying cash generation story. The group’s role...

While OOH Holdings Limited ( HKG:8091 ) shareholders have enjoyed a good week with stock up 12%, they need remain...

Angelalign Technology (SEHK:6699) just wrapped a busy August 31, reporting half year 2026 results alongside an interim ordinary dividend and a special payout, putting shareholder returns firmly in focus. Set against that strong half year update, Angelalign Technology’s share price has climbed 27.6% over the past 90 days and 44.8% year to date. The 1 year total shareholder return of 45.2% points to building momentum as investors reassess both growth prospects and perceived risk. Scan how...

Techtronic Industries Company Limited ( HKG:669 ) saw a double-digit share price rise of over 10% in the past couple of...

As Asian markets navigate a complex landscape of geopolitical tensions and fluctuating oil prices, investors are increasingly focused on finding opportunities that balance risk with potential growth. Penny stocks, though often associated with higher volatility, can still present valuable prospects when backed by solid financials. In this article, we will explore three Asian penny stocks that exhibit financial strength and growth potential, offering intriguing possibilities for those...

InnoCare Pharma (SEHK:9969) just received clearance from China’s Center for Drug Evaluation to begin clinical trials for ICP-B381, its first bispecific antibody drug conjugate targeting PSMA and STEAP1 in prostate cancer. The IND approval lands after a strong run in InnoCare Pharma’s share price, with a 90-day share price return of 44.82% and a 1-day move of 14.55% taking the stock to HK$15.51. However, the 1-year total shareholder return is still down 12.91%, while the 3-year total...

Guangdong Investment declared a total dividend of $1.86 per share, with an ex-dividend date that occurred on 14 September 2026 and cash payment scheduled for 17 November 2026. This extends a bi-annual dividend pattern in place since 2010. The firm now faces pressure as its long running dividend habit coincides with recent declines in dividend growth, revenue, EPS and EBITDA. This places fresh focus on how comfortably Guangdong Investment can support cash returns from its operating...